Diabetes treatment is constantly advancing, with new therapeutic options emerging to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the https://aadamqrzs609522.affiliatblogger.com/91182296/novel-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment